Share this
Angion and Elicio Therapeutics Enter Into Definitive Merger Agreement
January 19, 2023
Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Cell Therapy Programs
June 9, 2022
Immatics Enters Global Exclusive License Agreement With Bristol Myers Squibb
December 22, 2021
Otsuka Enters Worldwide Collaboration Agreement With Sunovion and Sumitomo Dainippon Pharma
Companies to advance four promising Sunovion compounds that address serious neuropsychiatric disorders • October 13, 2021